Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose

Bunchoo PongtanakulVip ViprakasitMahidol University2018-10-192018-10-192013-08-01Blood Cells, Molecules, and Diseases. Vol.51, No.2 (2013), 96-9710960961107997962-s2.0-84878403678https://repository.li.mahidol.ac.th/handle/20.500.14594/31256Mahidol UniversityBiochemistry, Genetics and Molecular BiologyMedicineTwice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily doseLetterSCOPUS10.1016/j.bcmd.2013.03.004